Hollsteen
← Amphenol

Cash and equivalents

Balance – as of period end · $B

QuartersFiscal years

$BCash and equivalents · Q1 2016: $687M · 10-Q 0001104659-16-118327 filed May 5, 2016Cash and equivalents · Q2 2016: $794M · 10-Q 0001104659-16-136887 filed Aug 4, 2016Cash and equivalents · Q3 2016: $854M · 10-Q 0001558370-16-009170 filed Nov 3, 2016Cash and equivalents · Q4 2016: $1.0B · 10-K 0001558370-17-000659 filed Feb 17, 2017Cash and equivalents · Q1 2017: $1.2B · 10-Q 0001558370-17-003547 filed May 4, 2017Cash and equivalents · Q2 2017: $1.3B · 10-Q 0001558370-17-005866 filed Aug 3, 2017Cash and equivalents · Q3 2017: $1.5B · 10-Q 0001558370-17-007980 filed Nov 2, 2017Cash and equivalents · Q4 2017: $1.7B · 10-K 0001558370-18-000871 filed Feb 21, 2018Cash and equivalents · Q1 2018: $1.0B · 10-Q 0001558370-18-003892 filed May 3, 2018Cash and equivalents · Q2 2018: $964M · 10-Q 0001558370-18-005948 filed Jul 31, 2018Cash and equivalents · Q3 2018: $998M · 10-Q 0001558370-18-007927 filed Oct 26, 2018Cash and equivalents · Q4 2018: $1.3B · 10-K 0001558370-19-000636 filed Feb 13, 2019Cash and equivalents · Q1 2019: $970M · 10-Q 0001558370-19-003426 filed Apr 26, 2019Cash and equivalents · Q2 2019: $982M · 10-Q 0001558370-19-006415 filed Jul 26, 2019Cash and equivalents · Q3 2019: $969M · 10-Q 0001558370-19-009160 filed Oct 25, 2019Cash and equivalents · Q4 2019: $891M · 10-K 0001558370-20-000728 filed Feb 12, 2020Cash and equivalents · Q1 2020: $2.4B · 10-Q 0001558370-20-004300 filed Apr 24, 2020Cash and equivalents · Q2 2020: $1.3B · 10-Q 0001558370-20-008390 filed Jul 24, 2020Cash and equivalents · Q3 2020: $1.4B · 10-Q 0001558370-20-011694 filed Oct 23, 2020Cash and equivalents · Q4 2020: $1.7B · 10-K 0001558370-21-000881 filed Feb 10, 2021Cash and equivalents · Q1 2021: $2.3B · 10-Q 0001558370-21-005338 filed Apr 30, 2021Cash and equivalents · Q2 2021: $1.2B · 10-Q 0001558370-21-009700 filed Jul 30, 2021Cash and equivalents · Q3 2021: $1.3B · 10-Q 0001558370-21-013825 filed Oct 29, 2021Cash and equivalents · Q4 2021: $1.2B · 10-K 0001558370-22-000961 filed Feb 9, 2022Cash and equivalents · Q1 2022: $1.2B · 10-Q 0001558370-22-006502 filed Apr 29, 2022Cash and equivalents · Q2 2022: $1.2B · 10-Q 0001558370-22-011379 filed Jul 29, 2022Cash and equivalents · Q3 2022: $1.2B · 10-Q 0001558370-22-015585 filed Oct 28, 2022Cash and equivalents · Q4 2022: $1.4B · 10-K 0001558370-23-001036 filed Feb 8, 2023Cash and equivalents · Q1 2023: $1.4B · 10-Q 0001558370-23-007328 filed Apr 28, 2023Cash and equivalents · Q2 2023: $1.3B · 10-Q 0001558370-23-012484 filed Jul 28, 2023Cash and equivalents · Q3 2023: $1.5B · 10-Q 0001558370-23-016952 filed Oct 27, 2023Cash and equivalents · Q4 2023: $1.5B · 10-K 0001558370-24-000866 filed Feb 7, 2024Cash and equivalents · Q1 2024: $1.9B · 10-Q 0001558370-24-005928 filed Apr 26, 2024Cash and equivalents · Q2 2024: $1.3B · 10-Q 0001558370-24-010246 filed Jul 26, 2024Cash and equivalents · Q3 2024: $1.6B · 10-Q 0001558370-24-013696 filed Oct 25, 2024Cash and equivalents · Q4 2024: $3.3B · 10-K 0001558370-25-000714 filed Feb 7, 2025Cash and equivalents · Q1 2025: $1.7B · 10-Q 0001558370-25-005558 filed Apr 25, 2025Cash and equivalents · Q2 2025: $3.2B · 10-Q 0001558370-25-009610 filed Jul 25, 2025Cash and equivalents · Q3 2025: $3.8B · 10-Q 0001104659-25-102142 filed Oct 24, 2025Cash and equivalents · Q4 2025: $11.1B · 10-K 0001104659-26-013549 filed Feb 11, 2026Cash and equivalents · Q1 2026: $4.1B · 10-Q 0001104659-26-054128 filed May 1, 2026Cash and equivalents · Q2 2026: $4.7B · 10-Q 0001104659-26-089194 filed Jul 31, 20261.74.70.711.1Q1 2016Q2 2026Q4 2017
$BCash and equivalents · Q4 2016: $1.0B · 10-K 0001558370-17-000659 filed Feb 17, 2017Cash and equivalents · Q1 2017: $1.2B · 10-Q 0001558370-17-003547 filed May 4, 2017Cash and equivalents · Q2 2017: $1.3B · 10-Q 0001558370-17-005866 filed Aug 3, 2017Cash and equivalents · Q3 2017: $1.5B · 10-Q 0001558370-17-007980 filed Nov 2, 2017Cash and equivalents · Q4 2017: $1.7B · 10-K 0001558370-18-000871 filed Feb 21, 2018Cash and equivalents · Q1 2018: $1.0B · 10-Q 0001558370-18-003892 filed May 3, 2018Cash and equivalents · Q2 2018: $964M · 10-Q 0001558370-18-005948 filed Jul 31, 2018Cash and equivalents · Q3 2018: $998M · 10-Q 0001558370-18-007927 filed Oct 26, 20181.71.01.0Q4 2016Q3 2018Q4 2017
Q4 2017
1.7$B
All values (42)
PeriodValue ($B)Status
Q2 20264.7reported
Q1 20264.1reported
Q4 202511.1reported
Q3 20253.8reported
Q2 20253.2reported
Q1 20251.7reported
Q4 20243.3reported
Q3 20241.6reported
Q2 20241.3reported
Q1 20241.9reported
Q4 20231.5reported
Q3 20231.5reported
Q2 20231.3reported
Q1 20231.4reported
Q4 20221.4reported
Q3 20221.2reported
Q2 20221.2reported
Q1 20221.2reported
Q4 20211.2reported
Q3 20211.3reported
Q2 20211.2reported
Q1 20212.3reported
Q4 20201.7reported
Q3 20201.4reported
Q2 20201.3reported
Q1 20202.4reported
Q4 20190.9reported
Q3 20191.0reported
Q2 20191.0reported
Q1 20191.0reported
Q4 20181.3reported
Q3 20181.0reported
Q2 20181.0reported
Q1 20181.0reported
Q4 20171.7reported
Q3 20171.5reported
Q2 20171.3reported
Q1 20171.2reported
Q4 20161.0reported
Q3 20160.9reported
Q2 20160.8reported
Q1 20160.7reported

CSV with all sources · Technical ID: cash

More metrics for Amphenol

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$1.7B
Period
Q4 2017, ended Dec 31, 2017 · as of Dec 31, 2017 (balance as of date, not a sum)
Source
10-K, filed Feb 21, 2018 · 0001558370-18-000871
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$1.7BFeb 21, 201810-K 0001558370-18-000871reported · confidence 1. · current